Acknowledgement
Supported by : 충남대학교
References
- Choi J, Hwang YK, Sung KW, Lee SH, Yoo KH, Jung HL, et al. Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia. Blood 2007;109:471-7 https://doi.org/10.1182/blood-2006-07-032557
- Mirebeau D, Acquaviva C, Suciu S, Bertin R, Dastugue N, Robert A, et al. The prognostic significance of CDKN2A, CDKN2B and MTAP inactivation in B-lineage acute lymphoblastic leukemia of childhood. Results of the EORTC studies 58881 and 58951. Haematologica 2006;91:881-5
- Lee DS, Lee JH, Min HC, Kim TY, Oh BR, Kim HY, et al. Application of high throughput cell array technology to FISH: investigation of the role of deletion of p16 gene in leukemias. J Biotechnol 2007;127:355-60 https://doi.org/10.1016/j.jbiotec.2006.07.019
- Sharpless NE. INK4a/ARF: a multifunctional tumor suppressor locus. Mutat Res 2005;576:22-38 https://doi.org/10.1016/j.mrfmmm.2004.08.021
- Van Zutven LJ, Van Drunen E, de Bont JM, Wattel MM, Den Boer ML, Pieters R, et al. CDKN2 deletions have no prognostic value in childhood precursor-B acute lymphoblastic leukaemia. Leukemia 2005;19:1281-4 https://doi.org/10.1038/sj.leu.2403769
- Schultz KR, Pullen DJ, Sather HN, Shuster JJ, Devidas M, Borowitz MJ, et al. Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG). Blood 2007;109:926-35 https://doi.org/10.1182/blood-2006-01-024729
- Conter V, Arico M, Valsecchi MG, Rizzari C, Testi A, Miniero R, et al. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica. Haematologica 1998;83:791-9
- Geradts J, Kratzke RA, Niehans GA, Lincoln CE. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression. Cancer Res 1995;55:6006-11
- Gonzalgo ML, Hayashida T, Bender CM, Pao MM, Tsai YC, Gonzales FA, et al. The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines. Cancer Res 1998;58:1245-52
- Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994;264:436-40 https://doi.org/10.1126/science.8153634
- Nomdedeu JF, Badell I, Estivill C, Carnicer MJ, Sierra J, Baiget M. TEL rearrangements in acute lymphobalstic leukemia: association with p16 deletions in relapsed cases. Haematologica 2001;86:547-8
- Kim NR, Lin Z, Kim KR, Cho HY, Kim I. Epstein-Barr virus and p16INK4A methylation in squamous cell carcinoma and precancerous lesions of the cervix uteri. J Korean Med Sci 2005;20:636-42 https://doi.org/10.3346/jkms.2005.20.4.636
- Bertin R, Acquaviva C, Mirebeau D, Guidal-Giroux C, Vilmer E, Cave H. CDKN2A, CDKN2B and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer 2003;37:44-57 https://doi.org/10.1002/gcc.10188
- Kim DH, Moldwin RL, Vignon C, Bohlander SK, Suto Y, Giordano L, et al. TEL-AML1 translocations with TEL and CDKN2 inactivation in acute lymphoblastic leukemia cell lines. Blood 1996;88:785-94
- Takasaki Y, Yamada Y, Sugahara K, Hayashi T, Dateki N, Harasawa H, et al. Interruption of p16 gene expression in adult T-cell leukaemia/lymphoma: clinical correlation. Br J Haematol 2003;122:253-9 https://doi.org/10.1046/j.1365-2141.2003.04377.x
- Tutor O, Diaz MA, Ramirez M, Algara P, Madero L, Martinez P. Loss of heterozygosity of p16 correlates with minimal residual disease at the end of the induction therapy in non-high risk childhood B-cell precursor acute lymphoblastic leukemia. Leuk Res 2002;26:817-20 https://doi.org/10.1016/S0145-2126(02)00020-6
- Heyman M, Rasool O, Borgonovo Brandter L, Liu Y, Grander D, Soderhall S, et al. Prognostic importance of p15INK4B and p16INK4 gene inactivation in childhood acute lymphocytic leukemia. J Clin Oncol 1996;14:1512-20 https://doi.org/10.1200/JCO.1996.14.5.1512
- Kees UR, Burton PR, Lu C, Baker DL. Homozygous deletion of the p16/MTS1 gene in pediatric acute lymphoblastic leukemia is associated with unfavorable clinical outcome. Blood 1997;89:4161-6
- Rubnitz JE, Behm FG, Pui CH, Evans WE, Relling MV, Raimondi SC, et al. Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL, and ETV6 gene abnormalities: results of St Jude Total Therapy Study XII. Leukemia 1997;11:1201-6 https://doi.org/10.1038/sj.leu.2400779
- Okuda T, Shurtleff SA, Valentine MB, Raimondi SC, Head DR, Behm F, et al. Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia. Blood 1995;85:2321-30
- Cooley LD, Chenevert S, Shuster JJ, Johnston DA, Mahoney DH, Carroll AJ, et al. Prognostic significance of cytogenetically detected chromosome 21 anomalies in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study. Cancer Genet Cytogenet 2007;175:117-24 https://doi.org/10.1016/j.cancergencyto.2007.02.007